Search - tctmd.com

Displaying 181 - 200 of 2029

Sort: Relevancy | Date

Presentation Intravascular Coronary Imaging and Physiology 2016

Use Imaging to Optimize and Understand BRS

Presenter: Alexandre Abizaid

March 10, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Role of OCT in Evaluation and treatment of In Stent Restenosis

Presenter: Andrew Lituchy

March 10, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Presenter: Ajay J. Kirtane

March 10, 2016

News Daily News

在出血风险高的患者中新一代 DES 加简化 DAPT 优于 BMS

L.A. McKeown

March 08, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Daily News

Los SLF de Nueva Generación Con Tratamiento Antiplaquetario Doble Abreviado Superan a los SMD en Pacientes de Alto Riesgo Hemorrágico

L.A. McKeown

March 08, 2016

Presentation

Is BMS Implantation Still Justifiable in High Bleeding Risk Patients Undergoing PCI?

Presenter: Sara Ariotti

March 07, 2016

News Daily News

新的分析未能证实 CTO PCI 成功和死亡率降低之间存在关联

Todd Neale

March 06, 2016

News Daily News

Un Nuevo Análisis No Halla un Nexo entre una PCI de Éxito en una OTC y una Menor Mortalidad

Todd Neale

March 06, 2016

News Daily News

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Todd Neale

March 06, 2016

Presentation

Successful Recanalization of Native Coronary CTO Is Not Associated With Improved Long-Term Survival

Presenter: Pil Hyung Lee

March 03, 2016

News Daily News

推迟任意类型的支架患者的非心脏手术至少一年：登记表分析

L.A. McKeown

March 01, 2016

News Daily News

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

L.A. McKeown

March 01, 2016

News Daily News

Análisis de Registro: Postponer Cirugías No Cardíacas al Menos 1 Año en Pacientes Con Cualquier Tipo de Stents

L.A. McKeown

March 01, 2016

Presentation

Cardiovascular Risk of Prior Stent Implantation Among Patients Undergoing Noncardiac Surgery

Presenter: Karim D. Mahmoud

February 29, 2016

News Industry News

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

February 28, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

News Daily News

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

Michael O'Riordan

February 23, 2016

News Industry News

REVA Achieves Target Patient Enrollment in FANTOM II Trial

February 23, 2016

News Daily News

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Michael O'Riordan

February 23, 2016

Advertisement

Use Imaging to Optimize and Understand BRS

Role of OCT in Evaluation and treatment of In Stent Restenosis

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

在出血风险高的患者中新一代 DES 加简化 DAPT 优于 BMS

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

Los SLF de Nueva Generación Con Tratamiento Antiplaquetario Doble Abreviado Superan a los SMD en Pacientes de Alto Riesgo Hemorrágico

Is BMS Implantation Still Justifiable in High Bleeding Risk Patients Undergoing PCI?

新的分析未能证实 CTO PCI 成功和死亡率降低之间存在关联

Un Nuevo Análisis No Halla un Nexo entre una PCI de Éxito en una OTC y una Menor Mortalidad

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Successful Recanalization of Native Coronary CTO Is Not Associated With Improved Long-Term Survival

推迟任意类型的支架患者的非心脏手术至少一年：登记表分析

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

Análisis de Registro: Postponer Cirugías No Cardíacas al Menos 1 Año en Pacientes Con Cualquier Tipo de Stents

Cardiovascular Risk of Prior Stent Implantation Among Patients Undergoing Noncardiac Surgery

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

REVA Achieves Target Patient Enrollment in FANTOM II Trial

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content